Health Net upgraded to Outperform from Market Perform at Wells Fargo Wells Fargo upgraded Health Net as it believes the company has addressed most of the challenges it faced in 2012. The firm raised its price target range for shares to $28-$30 from $26-$28.
Health Net downgraded to Sell from Buy at Citigroup Citigroup downgraded Health Net two notches to Sell from Buy citing the stock's 60% year-to-date rally and its belief that 2015 consensus estimates are too high. Citi thinks the company's dual enrollment in California is tracking well short of projections. It raised its price target for shares to $42 from $35.